# KBLB (Kraig Biocraft Laboratories, Inc.) - SEC EDGAR Financial Statements

> Kraig Biocraft Laboratories, Inc. reported $3.74M in total assets and a net loss of $3.88M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/KBLB
- Markdown: https://convexityos.com/fundamentals/KBLB.md
- SEC CIK: 0001413119
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:50 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001413119&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$3.39M | Operating profit |
| Net Income | FY 2025 | -$3.88M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.00 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$1.79M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $2.78M | Total debt: $190K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | -- | -- | $402K | $97K | $32K |
| Research & Development | $166K | $164K | $238K | $176K | $198K | $88K | $223K | $148K | $259K | $397K |
| Total Operating Expenses | $3.37M | $3.07M | $2.61M | $2.12M | $2.76M | $4.53M | $2.62M | $1.36M | $2.25M | $2.98M |
| **Operating Income** | -$3.37M | -$3.07M | -$2.61M | -$2.12M | -$2.76M | -$4.53M | -$2.62M | -$960K | -$2.16M | -$2.95M |
| **EBITDA** | -$3.35M | -$3.05M | -$2.59M | -$2.09M | -$2.73M | -$4.51M | -$2.59M | -$933K | -$2.14M | -$2.93M |
| Interest Income | -- | -- | $110K | -- | -- | -- | $6.4K | -- | -- | -- |
| Interest Expense | $571K | $530K | $485K | $154K | $238K | $5.5K | $294K | $229K | $177K | $139K |
| Income Before Tax | -$3.62M | -$3.40M | -$3.03M | -$3.84M | -$8.05M | -$4.97M | -$2.91M | -$1.17M | -$2.33M | -$3.07M |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | -- | $0 | $0 | $0 |
| **Net Income** | -$3.62M | -$3.40M | -$3.03M | -$3.84M | -$8.05M | -$4.97M | -$2.91M | -$1.17M | -$2.33M | -$3.07M |
| Basic EPS | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.01 | $0.00 | $0.00 | $0.00 | $0.00 |
| **Diluted EPS** | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.01 | $0.00 | $0.00 | $0.00 | $0.00 |
| Basic Shares Outstanding | 1.06B | 1.04B | 1.03B | 974.3M | 877.6M | 848.7M | 835.6M | 816.9M | 791.4M | 744.3M |
| Diluted Shares Outstanding | 1.06B | 1.04B | 1.03B | 974.3M | 877.6M | 848.7M | 835.6M | 816.9M | 791.4M | 744.3M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $3.0K | -- | -- | -- | -- | -- | -- | -- |
| Cost of Revenue | $4.3K | -- | -- | -- | -- | -- | -- | -- |
| **Gross Profit** | -$1.3K | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | $132K | $64K | $67K | $69K | $9.2K | $64K | $24K | $61K |
| Total Operating Expenses | $1.13M | $703K | $826K | $723K | $1.43M | $638K | $580K | $716K |
| **Operating Income** | -$1.14M | -$703K | -$826K | -$723K | -$1.43M | -$638K | -$580K | -$716K |
| **EBITDA** | -$1.13M | -$696K | -$819K | -$715K | -$1.43M | -$632K | -$575K | -$710K |
| Interest Expense | $153K | $151K | $148K | $144K | $144K | $142K | $140K | $136K |
| Income Before Tax | -$1.24M | -$910K | -$943K | -$788K | -$1.51M | -$726K | -$600K | -$852K |
| **Net Income** | -$1.24M | -$910K | -$943K | -$788K | -$1.51M | -$726K | -$600K | -$852K |
| Basic EPS | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- |
| **Diluted EPS** | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- |
| Basic Shares Outstanding | 1.12B | 1.11B | 1.09B | -- | 1.07B | 1.05B | 1.04B | -- |
| Diluted Shares Outstanding | 1.12B | 1.11B | 1.09B | -- | 1.07B | 1.05B | 1.04B | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.79M | $673K | $2.55M | $3.86M | $2.36M | $817K | $125K | $14K | $18K | $299K |
| Short-Term Investments | $0 | $0 | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $1.79M | $673K | $2.55M | $3.86M | $2.36M | $817K | $125K | $14K | $18K | $299K |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | -- | $26K | $32K |
| Inventory | $29K | $6.9K | $6.9K | $6.6K | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $1.87M | $740K | $2.57M | $3.98M | $2.37M | $819K | $157K | $21K | $48K | $332K |
| Property, Plant & Equipment, Net | $25K | $45K | $67K | $88K | $111K | $89K | $117K | $47K | $62K | $52K |
| **Total Non-Current Assets** | $697K | $765K | $659K | $587K | $656K | $458K | $594K | $51K | $66K | $52K |
| **Total Assets** | $2.57M | $1.51M | $3.23M | $4.57M | $3.02M | $1.28M | $751K | $71K | $114K | $384K |
| Accounts Payable | -- | -- | -- | $356K | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $10.45M | $9.61M | $8.89M | $8.07M | $8.16M | $7.45M | $5.58M | $4.53M | $3.49M | $2.74M |
| **Total Non-Current Liabilities** | $119K | $41K | $54K | $21K | $155K | $400K | $555K | $0 | $0 | $0 |
| **Total Liabilities** | $10.56M | $9.65M | $8.94M | $8.09M | $8.32M | $7.85M | $6.14M | $4.53M | $3.49M | $2.74M |
| **Total Debt (incl. Leases)** | $171K | $87K | $96K | $60K | $104K | $380K | $480K | -- | -- | -- |
| Common Stock | -- | -- | -- | -- | -- | -- | -- | $15.15M | $22K | $280K |
| Retained Earnings | -$56.71M | -$53.09M | -$49.69M | -$46.66M | -$42.81M | -$34.77M | -$29.80M | -$26.89M | -$25.72M | -$23.39M |
| **Total Stockholders' Equity** | -$8.00M | -$8.15M | -$5.71M | -$3.52M | -$5.30M | -$6.57M | -$5.39M | -$4.46M | -$3.38M | -$2.36M |
| Total Equity | -$8.00M | -$8.15M | -$5.71M | -$3.52M | -$5.30M | -$6.57M | -$5.39M | -$4.46M | -$3.38M | -$2.36M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.78M | $3.39M | $2.89M | $1.79M | $1.57M | $785K | $397K | $673K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Cash & Short-Term Investments** | $2.78M | $3.39M | $2.89M | $1.79M | $1.57M | $785K | $397K | $673K |
| Accounts Receivable, Net | $3.0K | -- | -- | -- | -- | -- | -- | -- |
| Inventory | $173K | $134K | $74K | $29K | $29K | $6.9K | $6.9K | $6.9K |
| **Total Current Assets** | $3.02M | $3.57M | $3.01M | $1.87M | $1.64M | $839K | $453K | $740K |
| Property, Plant & Equipment, Net | $63K | $54K | $33K | $25K | $31K | $37K | $39K | $45K |
| **Total Non-Current Assets** | $720K | $697K | $711K | $697K | $717K | $752K | $863K | $765K |
| **Total Assets** | $3.74M | $4.27M | $3.72M | $2.57M | $2.36M | $1.59M | $1.32M | $1.51M |
| **Total Current Liabilities** | $11.13M | $10.90M | $10.68M | $10.45M | $10.18M | $10.03M | $9.83M | $9.61M |
| **Total Non-Current Liabilities** | $112K | $121K | $106K | $119K | $128K | $34K | $38K | $41K |
| **Total Liabilities** | $11.24M | $11.02M | $10.78M | $10.56M | $10.31M | $10.06M | $9.86M | $9.65M |
| **Total Debt (incl. Leases)** | $190K | $194K | $18K | $171K | $184K | $59K | $73K | $87K |
| Retained Earnings | -$59.80M | -$58.56M | -$57.65M | -$56.71M | -$55.92M | -$54.41M | -$53.69M | -$53.09M |
| **Total Stockholders' Equity** | -$7.50M | -$6.75M | -$7.06M | -$8.00M | -$7.96M | -$8.47M | -$8.55M | -$8.15M |
| Total Equity | -$7.50M | -$6.75M | -$7.06M | -$8.00M | -$7.96M | -$8.47M | -$8.55M | -$8.15M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.62M | -$3.40M | -$3.03M | -$3.84M | -$8.05M | -$4.97M | -$2.91M | -$1.17M | -$2.33M | -$3.07M |
| Depreciation & Amortization | $25K | $26K | $28K | $28K | $26K | $28K | $31K | $27K | $20K | $17K |
| Stock-Based Compensation | $87K | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | $26K | $6.0K | -$32K |
| Change in Inventory | -$22K | -- | -$304 | -$6.6K | -- | -- | -- | -- | -- | -- |
| Change in Payables | -$12K | -$40K | $1.3K | $138K | $200K | $39K | $314K | $136K | $165K | -$16K |
| **Operating Cash Flow** | -$1.79M | -$1.84M | -$1.24M | -$1.89M | -$1.80M | -$1.25M | -$1.09M | -$235K | -$730K | -$1.01M |
| Capital Expenditure | -$5.4K | -$4.2K | -$6.4K | -$5.0K | -$97K | -- | -$101K | -$11K | -$31K | -$2.5K |
| **Free Cash Flow** | -$1.79M | -$1.84M | -$1.25M | -$1.89M | -$1.90M | -- | -$1.19M | -$246K | -$761K | -$1.01M |
| Purchases of Investments | -- | -- | -- | -- | -$450K | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | $438K | -$4.2K | -$6.4K | -$5.0K | -$547K | -- | -$101K | -$11K | -$31K | -$2.5K |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | $1.00M | $0 | $450K | $1.02M |
| **Financing Cash Flow** | $2.47M | -$35K | -$60K | $3.40M | $3.89M | $1.95M | $1.30M | $242K | $480K | $1.07M |
| **Net Change in Cash** | $1.12M | -$1.88M | -$1.31M | $1.51M | $1.54M | $692K | $111K | -$4.5K | -$281K | $61K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.24M | -$910K | -$943K | -$788K | -$1.51M | -$726K | -$600K | -$852K |
| Depreciation & Amortization | $5.4K | $7.1K | $6.2K | $7.6K | $6.0K | $5.8K | $5.7K | $6.1K |
| Stock-Based Compensation | $29K | $29K | $29K | -- | -- | -- | -- | -- |
| Change in Inventory | -$81K | -$60K | -$45K | -- | -- | -- | -- | -- |
| Change in Payables | $5.9K | -$15K | $15K | -$12K | -$34K | $22K | $12K | -$12K |
| **Operating Cash Flow** | -$594K | -$599K | -$530K | -$449K | -$462K | -$443K | -$434K | -$513K |
| Capital Expenditure | -$14K | -$29K | -$14K | -- | -- | -- | -- | -- |
| **Free Cash Flow** | -$608K | -$627K | -$544K | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | -$14K | -$29K | -$14K | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $0 | $1.13M | $1.64M | $602K | $1.02M | $688K | $158K | $0 |
| **Net Change in Cash** | -$608K | $501K | $1.10M | $225K | $780K | $388K | -$276K | -$517K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -- | -239.0% | -2215.4% | -9246.0% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -- | -291.1% | -2397.4% | -9648.6% |
| Return on Assets (ROA) | -141.2% | -225.8% | -93.7% | -84.1% | -266.2% | -389.2% | -387.5% | -1637.6% | -2037.7% | -801.2% |
| Current Ratio | 0.18x | 0.08x | 0.29x | 0.49x | 0.29x | 0.11x | 0.03x | 0.00x | 0.01x | 0.12x |
| Quick Ratio | 0.18x | 0.08x | 0.29x | 0.49x | 0.29x | 0.11x | 0.02x | 0.00x | 0.01x | 0.12x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | +312.7% | +205.5% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -103.9% | -97.1% | -106.6% | -141.2% | -156.5% | -164.1% | -265.3% | -225.8% |
| Current Ratio | 0.27x | 0.33x | 0.28x | 0.18x | 0.16x | 0.08x | 0.05x | 0.08x |
| Quick Ratio | 0.26x | 0.32x | 0.27x | 0.18x | 0.16x | 0.08x | 0.05x | 0.08x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
